“…In cannabis, bottom-up studies seem undeniably promising given the recent results obtained with existing PGPR strains (Citterio et al, 2005;Jin et al, 2014;Pagnani et al, 2018;Comeau et al, 2021), biocontrol agents (Balthazar et al, 2020(Balthazar et al, , 2021, or commercialized bioproducts (Gonsior et al, 2004;Conant et al, 2017;Kakabouki et al, 2021a,b;Punja, 2021;Punja and Ni, 2021;Scott and Punja, 2021), thus paving the way for future work with existing Pseudomonasbased bioproducts that are already registered for cereals, fruit trees, and greenhouse vegetables (Fischer et al, 2013;Khan et al, 2016). On the other hand, several top-down studies have also started to examine the potential of harnessing cannabis microbiome residents to improve pathogen control (Gautam et al, 2013;Kusari et al, 2013;Qadri et al, 2013;Scott et al, 2018;, salinity tolerance (Afzal et al, 2015), soil phytoremediation (Liste and Prutz, 2006;Iqbal et al, 2018), cannabinoid production , and fiber retting process (Di Candilo et al, 2010;Ribeiro et al, 2015;Liu et al, 2017;Law et al, 2020). In this regard, exploring the microbiome of wild cannabis plants and ancestral heirloom cultivars within their native Eurasian habitats could be of crucial importance to identify beneficial microorganisms that have associated with cannabis over long evolutionary periods.…”